Haleon PLC Sponsored ADR $HLN Shares Sold by Marks Group Wealth Management Inc

Key Points

• Marks Group Wealth Management Inc reduced its holdings in Haleon PLC Sponsored ADR by 42.7%, now owning 40,805 shares valued at approximately $423,000.
• Haleon recently declared a semi-annual dividend of $0.0555 per share, an increase from the previous $0.05 dividend.
• The stock has seen fluctuations, currently priced at $8.79, with a 1-year range between $8.71 and $11.42.

Marks Group Wealth Management Inc decreased its holdings in shares of Haleon PLC Sponsored ADR (NYSE:HLN - Free Report) by 42.7% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 40,805 shares of the company's stock after selling 30,414 shares during the period. Marks Group Wealth Management Inc's holdings in Haleon were worth $423,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also made changes to their positions in the business. Hanson & Doremus Investment Management boosted its holdings in Haleon by 234.1% during the second quarter. Hanson & Doremus Investment Management now owns 2,372 shares of the company's stock worth $25,000 after buying an additional 1,662 shares in the last quarter. Bartlett & CO. Wealth Management LLC raised its position in shares of Haleon by 135.9% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 2,588 shares of the company's stock worth $27,000 after purchasing an additional 1,491 shares during the period. Banque Transatlantique SA purchased a new stake in shares of Haleon during the first quarter valued at $27,000. Opal Wealth Advisors LLC acquired a new position in shares of Haleon in the 1st quarter valued at $29,000. Finally, Ransom Advisory Ltd purchased a new position in Haleon in the 1st quarter worth about $31,000. 6.67% of the stock is currently owned by institutional investors.

Haleon Stock Down 1.8%

Haleon stock opened at $8.79 on Tuesday. The company has a current ratio of 0.87, a quick ratio of 0.63 and a debt-to-equity ratio of 0.48. Haleon PLC Sponsored ADR has a 1-year low of $8.71 and a 1-year high of $11.42. The firm's fifty day simple moving average is $9.48 and its 200-day simple moving average is $10.06. The company has a market capitalization of $39.17 billion, a P/E ratio of 22.54, a P/E/G ratio of 2.65 and a beta of 0.20.

Haleon Increases Dividend

The business also recently declared a semi-annual dividend, which was paid on Thursday, September 18th. Stockholders of record on Friday, August 15th were paid a dividend of $0.0555 per share. This is a boost from Haleon's previous semi-annual dividend of $0.05. The ex-dividend date was Friday, August 15th. This represents a dividend yield of 190.0%. Haleon's dividend payout ratio is currently 28.21%.

Analyst Ratings Changes

HLN has been the subject of several recent analyst reports. Wall Street Zen cut Haleon from a "buy" rating to a "hold" rating in a research report on Saturday, July 12th. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Haleon in a research note on Saturday, September 27th. Barclays lowered shares of Haleon from an "overweight" rating to an "equal weight" rating in a research report on Tuesday, September 16th. Finally, The Goldman Sachs Group upgraded shares of Haleon from a "neutral" rating to a "buy" rating in a report on Wednesday, September 10th. One equities research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $12.33.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.